ArticleMolecular cancer therapeutics2024

Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer.

Sara G Danielli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.